Rectal Misoprostol
Rectal Misoprostol is a pharmaceutical formulation of the synthetic prostaglandin E1 analog administered via the rectal route to induce uterine contraction, distinguished from other routes of administration by its localized delivery and systemic absorption profile in the context of uterotonic therapy.
50
Publications
2K
Citations
240
Authors
94
Institutions
Publications per year
2017–2026
4
Parents
50
Oral, Rectal, and Vaginal Pharmacokinetics of Misoprostol
Rehan-Uddin Khan, Hazem El‐Refaey, Sunita Sharma et al. · Obstetrics and Gynecology · 2004 · 126 citations
Misoprostol Administered by Epithelial Routes
Karen Meckstroth, Amy K. Whitaker, Suzanne M. Bertisch et al. · Obstetrics and Gynecology · 2006 · 108 citations
Medicine, Obstetrics, Pharmacology +15
1–5 of 50
240
4
h-index
4
h-index
3
h-index
3
h-index
2
h-index
1–5 of 240
94
University College London
London, United Kingdom
4 h-index
16 publications
627 citations

University of the Witwatersrand
Johannesburg, South Africa
3 h-index
3 publications
207 citations

Ain Shams University
Cairo, Egypt
3 h-index
18 publications
359 citations
Chelsea and Westminster Hospital
London, United Kingdom
3 h-index
7 publications
739 citations

The Royal Free Hospital
London, United Kingdom
2 h-index
6 publications
327 citations
Obafemi Awolowo University Teaching Hospitals Complex
Ile-Ife, Nigeria
2 h-index
5 publications
86 citations
All India Institute of Medical Sciences
New Delhi, India
2 h-index
9 publications
126 citations

University College Hospital
London, United Kingdom
2 h-index
10 publications
300 citations
1–8 of 94
8 publications · 337 citations
8
h-index
6 publications · 420 citations
6
h-index
Repository · 4 publications · 70 citations
4
h-index
4 publications · 242 citations
4
h-index
4 publications · 94 citations
4
h-index
1–5